Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
9.25
+0.18 (1.98%)
At close: Jul 2, 2026, 4:00 PM EDT
9.07
-0.18 (-1.95%)
After-hours: Jul 2, 2026, 7:55 PM EDT

CRBP Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
171143144271477
Market Cap Growth
69.18%-0.25%437.89%92.36%-81.99%-37.57%
Enterprise Value
34.37-18.28-2.1126.7-20.226.09
Last Close Price
9.258.1411.806.043.3318.48
PS Ratio
-----87.49
PB Ratio
1.300.971.01-3.870.421.12
P/TBV Ratio
226.140.740.90-0.421.10
EV/Sales Ratio
-----6.90
EV/EBITDA Ratio
-0.210.04-0.52-
EV/EBIT Ratio
-0.210.04-0.51-
EV/FCF Ratio
-0.280.05-0.54-
Debt / Equity Ratio
-00.01-2.820.640.32
Net Debt / Equity Ratio
-1.08-1.10-1.020.00-1.03-1.03
Net Debt / EBITDA Ratio
1.531.903.0300.871.31
Net Debt / FCF Ratio
1.862.513.490.000.911.47
Asset Turnover
-00000.01
Quick Ratio
7.627.8912.610.664.685.74
Current Ratio
7.928.0712.940.744.765.89
Return on Equity (ROE)
-61.73%-54.18%-59.34%-341.99%-82.95%-79.80%
Return on Assets (ROA)
-57.46%-52.65%-52.91%-95.32%-45.78%-53.32%
Return on Invested Capital (ROIC)
-3598.60%-2310.98%-361.97%-273.13%-342.59%-441.05%
Return on Capital Employed (ROCE)
-65.61%-58.52%-69.38%-180.13%-55.18%-69.50%
Buyback Yield / Dilution
-25.70%-22.00%-152.23%-3.76%-1.85%-57.23%
Total Shareholder Return
-25.70%-22.00%-152.23%-3.76%-1.85%-57.23%
SEC Filings: 10-K · 10-Q